Information for media and journalists

Thank you for taking an interest in the story of Worldwide Cancer Research and the innovative discovery research we fund.  

Next

What do we offer to media?

We would be delighted to work with you to provide exclusive access to some of the most pioneering discovery research in the world, interviews with cancer experts, and access to cancer journey stories and unique fundraising case studies. 

Email our Press team

Our spokespeople:

Dr Helen Rippon, Chief Executive

Dr Helen Rippon was appointed Chief Executive of Worldwide Cancer Research in 2016, after spending four years as our Director of Research.

Before joining Worldwide Cancer Research, she held management positions in the third sector, with Prostate Cancer UK and Age UK. Helen has a PhD in Molecular Biology from the University of York and was a Postdoctoral Research Fellow at Imperial College London.

With two decades of experience in the field of cancer research, Helen has witnessed first-hand the positive steps and breakthroughs that have been made possible by the innovative discovery research Worldwide Cancer Research funds.  

The strides we are making gives us a real cause for optimism, there is still a way to go, but we’re taking so many positive steps in cancer research, treatment, prevention and diagnosis. This is thanks to an increase in our understanding of cancer, which has been made possible by the discovery research we fund and the amazing Curestarters who support this work.

Dr Helen Rippon Chief Executive

Our worldwide impact since 1979:

  • £213m+
    of funding on...
  • 2,000+
    innovative projects in...
  • 450+
    different research institutes in...
  • 5
    continents and...
  • 35
    countries around the world

News & Press

News and press
Remember a Charity Week 2024
Remember a Charity Week
Worldwide Cancer Research team working at desk
News and press
New website launch
New Worldwide Cancer Research website launched
News and press
Exciting new immunotherapy breakthrough
Exciting new immunotherapy breakthrough